LUO YING enters GYRE THERAPEUTICS, INC. with 2.58M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.58M | Indirect |
| Total | 2.58M | 2.58M indirect |
Stock Option (Right to Buy)
IndirectUnderlying shares
2.26M
Shares owned
N/A
Exercise price
0.75
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
988.62K
Shares owned
N/A
Exercise price
2
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
3.38M
Shares owned
N/A
Exercise price
0.75
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
199.63K
Shares owned
N/A
Exercise price
2
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
475.30K
Shares owned
N/A
Exercise price
0.32
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
235.27K
Shares owned
N/A
Exercise price
5.98
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
237.65K
Shares owned
N/A
Exercise price
0.93
Expiration
—
Exercise window
—
Underlying
7.78M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Indirect | Common Stock | 0.75 | — | — | 2.26M | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2 | — | — | 988.62K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.75 | — | — | 3.38M | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2 | — | — | 199.63K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.32 | — | — | 475.30K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 5.98 | — | — | 235.27K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.93 | — | — | 237.65K | N/A |
| Total | 7.78M | 0.00 | ||||